# Corticosteroids for PJP in Non-HIV Immunocompromised Adults

> **NCT07152613** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Qingyuan Zhan** · enrollment: 240 (estimated)

## Conditions studied

- Pneumocystis Jiroveci Pneumonia

## Interventions

- **DRUG:** Saline (0.9%, sterile, for infusion)
- **DRUG:** Low Dose Corticosteroids
- **DRUG:** Moderate dose corticosteroids

## Key facts

- **NCT ID:** NCT07152613
- **Lead sponsor:** Qingyuan Zhan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-08
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07152613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07152613, "Corticosteroids for PJP in Non-HIV Immunocompromised Adults". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07152613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*